What If an Epidural Steroid Injection Doesn’t Work?

Roughly half of people who receive an epidural steroid injection for back or leg pain do not get meaningful relief. One prospective study tracking patients over three weeks found that about 53% never reached even a 50% reduction in pain at any point after the injection. That does not mean the situation is hopeless. It means a failed injection is common enough that pain specialists have well-established pathways for what comes next, from reconsidering the diagnosis to trying a different type of procedure altogether. The reasons an injection falls short vary widely, and understanding those reasons shapes what you should do about it.

How Long Should You Wait Before Calling It a Failure

One of the first questions after a disappointing injection is whether you gave it enough time. The answer, based on tracking data, is that most people who are going to respond know within the first few days. In a study that followed 108 patients with daily pain diaries after an epidural steroid injection, about 47% ultimately had a successful outcome at three weeks. Among those responders, nearly three-quarters reported meaningful relief by day one, and another 22% reached that threshold by day four. Only a small handful of successes first appeared after two weeks.¹

So if you are sitting at the one-week mark with no change, the odds of a late turnaround are low. That said, steroid medications can take time to reduce inflammation fully, and mild improvements sometimes build gradually. The practical cutoff most clinicians use is two to four weeks. If you have had zero improvement by then, it is reasonable to call it and move on to the next step rather than waiting indefinitely.

The Diagnosis Might Be Wrong

An epidural steroid injection targets inflammation around spinal nerves, most commonly from a herniated disc pressing on a nerve root. When the injection fails, one of the most productive questions is whether that was actually the source of your pain in the first place. Back pain is notoriously difficult to pin down, and imaging findings do not always match what is causing the symptoms.

Facet joints, the small paired joints along the back of the spine, are a good example. These joints can generate pain that mimics disc-related sciatica, and they account for a substantial share of chronic low back pain in older adults. The problem is that MRI is poor at visualizing the structures most involved in facet pain, such as the joint capsule and the tiny medial branch nerves that transmit pain signals from those joints. This means a patient can have a clean-looking MRI, get steered toward an epidural injection for a presumed disc problem, and fail to improve because the real pain generator was a facet joint that never showed up clearly on imaging.²

Sacroiliac joint dysfunction, hip pathology, and even piriformis syndrome can all produce pain patterns that overlap with lumbar radiculopathy. If an epidural injection did nothing, a careful re-evaluation by your pain specialist or spine physician is worth more than simply repeating the same procedure and hoping for a different result. Diagnostic nerve blocks, where a small amount of numbing medication is placed near a specific structure, can help isolate the true source of pain when imaging and clinical exam are ambiguous.

What the Underlying Condition Tells You About Your Odds

Not all spinal conditions respond equally well to epidural steroids. The evidence consistently shows that disc herniations and central spinal stenosis tend to respond better than other diagnoses. A study examining predictors of success found that having a disc herniation or central stenosis, along with higher baseline disability, increased the odds of a meaningful improvement in function at three months.³

This makes intuitive sense. A herniated disc that is compressing a nerve root and triggering local inflammation is exactly the kind of problem a steroid bath can help. The steroid reduces the chemical irritation around the nerve, even if the disc is still bulging. Conditions where pain is driven more by structural compression without much inflammatory component, or by changes in how the nervous system processes pain signals, tend to be harder to treat with a local steroid alone.

Neuropathic pain can arise from several different mechanisms: direct mechanical compression of a nerve root, chemical irritation from inflammatory substances leaking out of a degenerating disc, or damage to the tiny nerve fibers that have grown into the disc itself.⁴ When the dominant mechanism is inflammatory, steroids have a fighting chance. When the pain is driven by structural compression or by changes in the central nervous system’s pain processing, the injection is working against longer odds.

Did the Injection Route Matter

Epidural steroid injections can be delivered through three different approaches: transforaminal (from the side, targeting a specific nerve root), interlaminar (from the back, entering the epidural space between vertebral arches), and caudal (through the sacral hiatus at the base of the spine). If your injection did not work, it is natural to wonder whether a different approach might succeed.

The evidence here is somewhat mixed but leans toward the routes being broadly comparable for most patients. One trial comparing all three approaches for lumbar disc herniation found similar efficacy across the board.⁵ Another study comparing transforaminal and interlaminar routes found no significant difference in pain or function scores at one, three, or six months.⁶

That said, one study did find the transforaminal route significantly outperformed the caudal and interlaminar approaches at six months and one year, with improvement rates of 90% for transforaminal versus about 74-78% for the other two routes.⁷ The transforaminal approach has the advantage of placing medication right next to the affected nerve root, which may explain why some studies show a slight edge, even if others do not. If you had a caudal injection that failed and your anatomy allows it, asking your doctor about a transforaminal approach for a repeat attempt is reasonable, though the overall evidence does not guarantee a dramatically different result.

Your Brain and Nervous System Play a Larger Role Than You Might Think

Pain is not just about what is happening at the disc or nerve root. Your central nervous system can amplify pain signals in ways that make local treatments less effective. This phenomenon, sometimes called central sensitization, means the brain and spinal cord have become hypersensitive, continuing to generate pain even when the original tissue injury has calmed down. It is especially common in people who have had pain for months or years.

Research has shown that patients with signs of central sensitization respond more poorly to transforaminal epidural steroid injections. They tend to report worse pain scores, more disability, and worse mental health outcomes after the procedure compared to patients without those features.⁸ This is not a failure of the injection in the mechanical sense; the steroid may have done its job at the nerve root, but the pain signal has been rewired upstream.

If this sounds familiar, treatments that address central sensitization directly tend to be more productive than repeating injections. These include structured physical therapy programs, cognitive behavioral therapy for pain, medications that calm nervous system excitability, graded exercise programs, and mindfulness-based stress reduction. None of these are “it’s all in your head” dismissals. Central sensitization is a real neurological change, and it responds to real treatments that target the nervous system rather than the spine.

Individual Biology and Why Response Varies So Much

Research has begun to uncover biological markers that help explain why some people respond to epidural steroids and others do not. In one study, only about 35% of subjects with axial low back pain responded to the injection. Responders had measurably different blood levels of certain biomarkers before the injection even happened, including higher levels of neuropeptide Y and serotonin. The study also found that a specific genetic variant in the COMT gene, which affects how the body processes pain-related chemicals, was associated with better odds of responding to the injection.⁹

This kind of personalized medicine is still in its early stages for spine pain. No clinic is currently running a blood panel to predict your injection response before scheduling you. But it underscores an important point: whether the injection works is not purely about your disc or your doctor’s technique. Your individual biochemistry plays a meaningful role, and a failed injection does not necessarily mean the diagnosis was wrong or the procedure was botched.

One factor that does not appear to matter much is body weight. A study comparing outcomes across patients with and without obesity found no significant differences in pain, disability, or quality-of-life scores at three months, regardless of whether BMI was under 30, between 30 and 40, or above 40.¹⁰ If someone suggests the injection failed because of your weight, the data does not support that explanation.

Trying Another Injection or a Series

Many patients receive a series of two or three injections rather than a single shot. One long-term follow-up study of patients receiving fluoroscopically guided transforaminal injections found that about 75% achieved a successful outcome after an average of just under two injections per patient, with follow-up extending to an average of about 80 weeks.¹¹ So some patients who do not respond fully to one injection do benefit from a second.

There is a meaningful difference, though, between getting partial relief and getting zero relief. If your first injection took the edge off for a few days or reduced your leg pain somewhat before it crept back, a repeat injection at a slightly different level or with a different steroid formulation may build on that partial response. If you felt absolutely nothing from the first injection, repeating the exact same procedure is harder to justify. A conversation with your provider about whether the diagnosis and approach need revisiting before scheduling a repeat is the better move.

Risks of Repeating Injections Without a Plan

Epidural steroids are not harmless, and the risks accumulate with repeated exposure. The steroid does not stay at the injection site; it gets absorbed into the bloodstream and can affect your entire body. One study found that patients who had received multiple epidural steroid injections before undergoing spine surgery had lower baseline cortisol levels than patients who had not, and their adrenal glands failed to mount a normal stress response after surgery.¹² This adrenal suppression means the body may temporarily lose its ability to produce adequate cortisol on its own, which can be a problem during the physical stress of surgery or illness.

There are also skeletal concerns. A review of the literature found that systemic steroid absorption after epidural injections can cause blood sugar spikes, suppress the body’s own cortisol production, and may reduce bone mineral density. Several studies have found a relationship between epidural steroid exposure and lower bone density, and a dose-response pattern has been reported for spine bone density specifically.¹³ For someone who already has osteoporosis or is at risk for it, stacking injection after injection without a clear plan is worth thinking twice about.

Most guidelines suggest limiting epidural steroid injections to three or four per year. If you have had several rounds without benefit, pushing for more of the same is unlikely to change the outcome and starts to carry real downside.

Platelet-Rich Plasma as an Alternative Injectate

Platelet-rich plasma, or PRP, has generated interest as a potential replacement for steroids in epidural injections. PRP is made from your own blood: a sample is drawn, spun in a centrifuge to concentrate the platelets and growth factors, and then injected. The idea is that instead of suppressing inflammation with a steroid, you deliver growth factors that promote healing.

Two recent meta-analyses of randomized trials have compared epidural PRP to epidural steroids for lumbar disc disease with radiculopathy. One found that PRP offered comparable pain relief, functional improvement, and overall health gains at all observed time points, with a similar safety profile.¹⁴ The other found that steroids provided a slight early advantage in disability scores at four weeks, but the two treatments converged at later time points with no significant differences.¹⁵

PRP is not going to rescue a situation where the underlying diagnosis is wrong, but for patients who cannot tolerate repeated steroid exposure due to diabetes, osteoporosis, or adrenal concerns, it represents a biologically different option with similar effectiveness. The catch is that PRP injections are often not covered by insurance and can cost several hundred dollars out of pocket.

When Surgery Becomes the Better Option

Surgery is not the automatic next step after a failed injection, but it is the right next step for certain patients. If imaging shows a clear structural problem, such as a large disc herniation compressing a nerve root, and your pain has not responded to conservative and interventional treatments over a reasonable period, surgery can be highly effective. A study of microdiscectomy in younger, active patients found that about 84% returned to full activity, leg pain scores dropped by an average of nearly 5 points on a 10-point scale, and 85% were satisfied with the outcome.¹⁶

The key distinction is between patients with a well-defined structural lesion that matches their symptoms and patients with more diffuse or ambiguous pain. Surgery works best when there is a clear target. For spinal stenosis, decompression procedures can relieve leg pain and improve walking tolerance. For disc herniations, microdiscectomy removes the fragment pressing on the nerve. The conversation about surgery is most productive when the injection failure has helped clarify the diagnosis rather than just adding to the frustration.

Spinal Cord Stimulation for Chronic Refractory Pain

For patients whose pain has resisted injections, physical therapy, medications, and sometimes even surgery, spinal cord stimulation is an option worth knowing about. A spinal cord stimulator is a small device implanted near the spine that delivers mild electrical pulses to interrupt pain signals before they reach the brain. You typically go through a trial period with a temporary device before committing to a permanent implant.

A recent meta-analysis comparing spinal cord stimulation to conventional medical management found significantly greater reductions in pain, better physical function, and improved quality of life at six months, with benefits maintained for up to two years in non-randomized follow-up data.¹⁷ A European multicenter study using high-frequency stimulation at 10 kHz found that about 64% of implanted patients achieved at least a 50% pain reduction at three months, with that response rate holding steady through one year.¹⁸

Spinal cord stimulation is not a first-line treatment. It is designed for people who have already tried and failed more conservative options. But for chronic, intractable pain that has not responded to anything else, the evidence is reasonably strong that it can provide meaningful relief for a majority of carefully selected patients.

Epidural Adhesions After Previous Surgery

If you have had prior spine surgery and your epidural steroid injections are not working, scar tissue may be part of the problem. Epidural fibrosis, the buildup of scar tissue in the epidural space after surgery, has been reported as a contributing factor in a large share of cases of persistent pain after back surgery. This scar tissue can tether nerve roots, prevent injected medication from reaching the target, and generate pain on its own.¹⁹

Epidurolysis, a procedure that mechanically breaks up scar tissue using a catheter threaded into the epidural space, is one option for these patients. When performed endoscopically, the technique has been shown to improve chronic pain in roughly one-third to one-half of patients with symptomatic adhesions. It is a niche procedure and not widely available, but if your pain specialist suspects scar tissue is the reason your injections keep failing, it is a reasonable avenue to explore.

Cost and the Question of Diminishing Returns

When an injection does work, it tends to be cost-effective. A pilot study comparing epidural steroids plus physical therapy and medications to physical therapy and medications alone found the injection group achieved better quality-of-life improvement at lower overall cost within three months.²⁰ But that calculation changes when injections are not working. Each additional unsuccessful injection adds cost without benefit, delays more definitive treatment, exposes you to steroid side effects, and can erode your trust in the treatment process.

If you have had two injections with no improvement, the cost-effectiveness math shifts decisively toward either investigating a different diagnosis or pursuing the next tier of treatment. Physicians who keep scheduling injections without re-evaluating the clinical picture are not following best practices, and you are within your rights to ask for a different approach or a referral to a spine surgeon or a multidisciplinary pain program. The goal is not to exhaust every possible injection before trying something else. The goal is to match the right treatment to the right diagnosis, and a failed injection is a data point that helps narrow that down.